NS
VKTX icon

NBC Securities’s Viking Therapeutics VKTX Stock Holding History

NBC Securities’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$73.6K Hold
2,262
– – 0.01% 1181
2025
Q4 		$79.6K Sell
2,262
-165
-7% -$5.85K 0.01% 1160
2025
Q3 		$63.8K Sell
2,427
-146
-6% -$4.36K ﹤0.01% 1224
2025
Q2 		$68K Buy
2,573
+351
+16% +$9.24K 0.01% 1207
2025
Q1 		$53K Buy
2,222
+2,221
+222,100% +$70.2K ﹤0.01% 1155
2024
Q4 		$52 Sell
1
-1,130
-100% -$64.4K ﹤0.01% 1034
2024
Q3 		$71K Buy
1,131
+113
+11% +$6.63K 0.01% 1076
2024
Q2 		$53K Buy
+1,018
New +$66.7K ﹤0.01% 1128

Other funds holding VKTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

NBC Securities's VKTX Position: Q1 2026 in Review

NBC Securities held its Viking Therapeutics (VKTX) position steady in Q1 2026 at 2,262 shares worth $73.6K. The position accounts for 0.01% of the portfolio, ranked #1181.

NBC Securities first reported a position in VKTX in Q2 2024 and has held it in 8 quarters since. The position peaked at $79.6K in Q4 2025. 410 funds tracked by Wall St. Rank hold VKTX as of Q1 2026.

  • NBC Securities held 2,262 shares of Viking Therapeutics worth $73.6K as of Q1 2026.
  • NBC Securities left its Viking Therapeutics share count unchanged in Q1 2026.
  • Viking Therapeutics made up 0.01% of NBC Securities's portfolio in Q1 2026, its #1181 holding.
  • NBC Securities first reported a position in Viking Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • NBC Securities's Viking Therapeutics position peaked at $79.6K in Q4 2025.
  • 410 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2026.

Based on NBC Securities's 13F filing for Q1 2026, filed 14 Apr 2026.